Free Trial

CureVac (CVAC) SEC Filings & 10K Form

$3.69
-0.28 (-7.05%)
(As of 05/24/2024 04:00 PM ET)

Recent CureVac SEC Filings

DateFilerForm TypeView
05/24/2024
6:54 AM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2024
3:30 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2024
3:15 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2024
3:20 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2024
3:15 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/12/2024
3:48 PM
CureVac (Subject)
Greune Malte (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/04/2024
3:15 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/06/2024
4:10 PM
CureVac (Subject)
GSK plc (Filed by)
Form SC 13G/A
01/17/2024
8:02 AM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/05/2024
3:15 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/05/2024
2:19 PM
CureVac (Subject)
Mendila Myriam (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2024
1:57 PM
CureVac (Subject)
Greune Malte (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2024
2:09 PM
CureVac (Subject)
Zehnder Alexander (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2024
1:41 PM
CureVac (Subject)
Kemula Pierre (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2023
3:30 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2023
3:15 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2023
3:45 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/12/2023
3:15 PM
CureVac (Filer)
Form 20-F/A
09/28/2023
3:30 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/17/2023
3:30 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/17/2023
3:30 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/14/2023
3:01 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/13/2023
3:01 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2023
3:45 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2023
3:45 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2023
5:03 AM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2023
4:20 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2023
3:15 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2023
3:20 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CVAC) was last updated on 5/27/2024 by MarketBeat.com Staff

From Our Partners